Heart failure is the major cause of morbidity and mortality in the United States. Stage D heart failure has a greater mortality rate than many cancers and has equivalent symptom burden and severity. There has been a paradigm shift in our understanding of the pathophysiology of heart failure. Progressive heart failure is associated with ventricular remodeling and a maladaptive neurohumoral response. Drug classes have evolved that curtail ventricular remodeling, and blunt neurohumoral responses reduce morbidity and mortality. Despite combination drug and device therapies, the management of Stage D heart failure includes palliation. Both cardiology and palliative specialists need to learn from one another in order to palliate these highly symptomatic patients. Such collaboration will enhance care and are the basis for well-conceived research trials.
Remme WJ, Swedberg K: Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail. 2002; 4(1): 11-22.
2.
Hunt SA, Baker DW, Chin MH, et al.: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2001; 104(24): 2996-3007.
3.
Jessup M, Brozena S: Heart failure. N Engl J Med. 2003; 348(20): 2007-2018.
4.
Simon J, Gibbs R: Heart disease. In Addington-Hall JM, Higginson IJ (eds.): Palliative Care for Non-Cancer Patients. London: Oxford University Press, 2001.
5.
Friesinger GC 2nd, Butler J: End-of-life care for elderly patients with heart failure. Clin Geriatr Med. 2000; 16(3): 663-675.
6.
Albert NM, Davis M, Young J: Improving the care of patients dying of heart failure. Cleve Clin J Med. 2002; 69(4): 321-328.
7.
Krumholz HM, Parent EM, Tu N, et al.: Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997; 157(1): 99-104.
8.
Blyth FM, Lazarus R, Ross D, et al.: Burden and outcomes of hospitalization for congestive heart failure. Med J Austral. 1997; 167(2): 67-70.
9.
McMurray J, McDonagh T, Morrison CE, et al.: Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J. 1993; 14(9): 1158-1162.
10.
Ellershaw J, Ward C: Care of the dying patient: The last hours or days of life. BMJ. 2003; 326(7379): 30-34.
11.
Chen HH, Lainchbury JG, Senni M, et al.: Diastolic heart failure in the community: Clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. J Card Fail. 2002; 8(5): 279-287.
12.
Brophy JM, Deslauriers G, Rouleau JL: Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol. 1994; 10(5): 543-547.
13.
Konstam MA, Rousseau MF, Kronenberg MW, et al.: Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation. 1992; 86(2): 431-438.
14.
Benedict CR, Shelton B, Johnstone DE, et al.: Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation. 1996; 94(4): 690-697.
15.
Koilpillai C, Quinones MA, Greenberg B, et al.: Relation of ventricular size and function to heart failure status and ventricular dysrhythmia in patients with severe left ventricular dysfunction. Am J Cardiol. 1996; 77(8): 606-611.
16.
Pritzker MR: Chronic heart failure and the quality of life. N Engl J Med. 1999; 340(19): 1511.
17.
Gorkin L, Schron EB, Brooks MM, et al.: Psychosocial predictors of mortality in the Cardiac Arrhythmia Suppression Trial-1 (CAST-1). Am J Cardiol. 1993; 71(4): 263-267.
18.
Conraads VM, Bosmans JM, Vrints CJ: Chronic heart failure: An example of a systemic chronic inflammatory disease resulting in cachexia. Int J Cardiol. 2002; 85(1): 33-49.
19.
McCarthy M, Lay M, Addington-Hall J: Dying from heart disease. J R Coll Physicians Lond. 1996; 30(4): 325-328.
20.
Lynn J, Harrell F Jr, Cohn F, et al.: Prognoses of seriously ill hospitalized patients on the days before death: Implications for patient care and public policy. New Horiz. 1997; 5(1): 56-61.
21.
Levenson JW, McCarthy EP, Lynn J, et al.: The last six months of life for patients with congestive heart failure. J Am Geriatr Soc. 2000; 48(5 Suppl): S101-S109.
22.
Faris R, Purcell H, Henein MY, et al.: Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail. 2002; 4(4): 541-551.
23.
Koenig HG: Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry. 1998; 20(1): 29-43.
24.
Murberg TA, Bru E, Svebak S, et al.: Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: A two-year follow-up study. Int J Psychiatry Med. 1999; 29(3): 311-326.
25.
Vaccarino V, Kasl SV, Abramson J, et al.: Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol. 2001; 38(1): 199-205.
26.
Jiang W, Alexander J, Christopher E, et al.: Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001; 161(15): 1849-1856.
27.
Anker SD, Sharma R: The syndrome of cardiac cachexia. Int J Cardiol. 2002; 85(1): 51-66.
28.
Nohria A, Lewis E, Stevenson LW: Medical management of advanced heart failure. JAMA. 2002; 287(5): 628-640.
29.
Leung RS, Bowman ME, Parker JD, et al.: Avoidance of the left lateral decubitus position during sleep in patients with heart failure: Relationship to cardiac size and function. J Am Coll Cardiol. 2003; 41(2): 227-230.
30.
Jaarsma T, Halfens R, Abu-Saad HH, et al.: Quality of life in older patients with systolic and diastolic heart failure. Eur J Heart Fail. 1999; 1(2): 151-160.
31.
Riegel B, Bennett JA, Davis A, et al.: Cognitive impairment in heart failure: issues of measurement and etiology. Am J Crit Care. 2002; 11(6): 520-528.
32.
Krumholz HM, Phillips RS, Hamel MB, et al.: Resuscitation preferences among patients with severe congestive heart failure: Results from the SUPPORT project. Circulation. 1998; 98(7): 648-655.
33.
Golin CE, Wenger NS, Liu H, et al.: A prospective study of patient-physician communication about resuscitation. J Am Geriatr Soc. 2000; 48(5 Suppl): S52-S60.
34.
Drazner MH, Rame JE, Stevenson LW, et al.: Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 2001; 345(8): 574-581.
35.
Das MK, Cheriparambil K, Bedi A, et al.: Prolonged QRS duration (QRS D170 ms) and left axis deviation in the presence of left bundle branch block: A marker of poor left ventricular systolic function?Am Heart J. 2001; 142(5): 756-759.
36.
Kearney MT, Zaman A, Eckberg DL, et al.: Cardiac size, autonomic function, and 5-year follow-up of chronic heart failure patients with severe prolongation of ventricular activation. J Card Fail. 2003; 9(2): 93-99.
37.
Abraham WT, Fisher WG, Smith AL, et al.: Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002; 346(24): 1845-1853.
38.
Abraham WT: Electrophysiological aids in congestive heart failure: Supporting and synchronizing systole. Med Clin North Am. 2003; 87(2): 509-521.
39.
Cheng V, Kazanagra R, Garcia A, et al.: A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study. J Am Coll Cardiol. 2001; 37(2): 386-391.
40.
Berger R, Huelsman M, Strecker K, et al.: B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002; 105(20): 2392-2397.
41.
Ward C: The need for palliative care in the management of heart failure. Heart. 2002; 87(3): 294-298.
42.
Lynn J, Teno JM, Phillips RS, et al.: Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT Investigators. Ann Intern Med. 1997; 126(2): 97-106.
43.
Quaglietti SE, Atwood JE, Ackerman L, et al.: Management of the patient with congestive heart failure using outpatient, home, and palliative care. Prog Cardiovasc Dis. 2000; 43(3): 259-274.
44.
Gottlieb FC: Outcomes research: Evaluating the impact of echocardiography in congestive heart failure. J Am Coll Cardiol. 1999; 33(1): 171-173.
45.
Young J: Heart failure: Highlights from new consensus guidelines. Cleve Clin J Med. 2000; 67(1): 13-16.
46.
Stewart S, McMurray J: Palliative care for heart failure: Time to move beyond treating and curing to improving the end of life. Br Med J (Clin Res Ed). 2002; 325(7370): 915-916.
47.
Weber KT: Mechanisms of disease: Aldosterone in congestive heart failure. N Engl J Med. 2001; 345(23): 1689-1697.
48.
Murray DR, Dugan J: Overview of recent clinical trials in heart failure: What is the current standard of care?Cardiol Rev. 2000; 8(6): 340-347.
49.
Durand JB: Current guidelines in heart failure management. Ethn Dis. 2002; 12(1): S1-3-S1-11.
50.
Cleland JG: Are symptoms the most important target for therapy in chronic heart failure?Prog Cardiovasc Dis. 1998; 41(Suppl 1): 59-64.
51.
Cleland JG, Freemantle N, Eastaugh JL, et al.: Angiotensin converting enzyme inhibitors for heart failure. The Cochrane Database of Systematic Reviews, 2003.
52.
Schiffrin EL: Vascular and cardiac benefits of angiotensin receptor blockers. Am J Med. 2002; 113(5): 409-418.
53.
Jong P, Demers C, McKelvie R, et al.: Angiotensin receptor blockers for heart failure. The Cochrane Database of Systematic Reviews, 2003.
54.
McMurray J, Pfeffer MA: New therapeutic options in congestive heart failure: Part I. Circulation. 2002; 105(17): 2099-2106.
55.
Cleland JG, Freemantle N, Estaugh JL, et al.: Beta-blockers for heart failure. The Cochrane Database of Systematic Reviews, 2003.
Packer M, Coats AJ, Fowler MB, et al.: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001; 344(22): 1651-1658.
58.
Hood WBJ, Dans AL, Guyatt GH, et al.: Digitalis for treatment of congestive heart failure. in patients with sinus rhythm. The Cochrane Database of Systematic Reviews, 2003.
59.
Rathore SS, Curtis JP, Wang Y, et al.: Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003; 289(7): 871-878.
60.
Faris R, Purcell H, Henein MY, et al.: Diuretics for heart failure. The Cochrane Database of Systematic Reviews, 2003.
Lahav M, Regev A, Ra’anani P, et al.: Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. Chest. 1992; 102(3): 725-731.
63.
Salvador DR, Rey NR, Ramos GC, et al.: Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. The Cochrane Database of Systematic Reviews, 2004.
64.
Dormans TP, van Meyel JJ, Gerlag PG, et al.: Diuretic efficacy of high dose furosemide in severe heart failure: Bolus injection versus continuous infusion. J Am Coll Cardiol. 1996; 28(2): 376-382.
65.
Schuller D, Lynch JP, Fine D: Protocol-guided diuretic management: Comparison of furosemide by continuous infusion and intermittent bolus. Crit Care Med. 1997; 25(12): 1969-1975.
66.
Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999; 341(10): 709-717.
67.
Pitt B, Remme W, Zannad F, et al.: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003; 348(14): 1309-1321.
68.
Felker GM, O’Connor CM: Inotropic therapy for heart failure: An evidence-based approach. Am Heart J. 2001; 142(3): 393-401.
69.
Jennings AL, Davies AN, Higgins JP, et al.: Opioids for the palliation of breathlessness in terminal illness. The Cochrane Database of Systematic Reviews, 2001.
70.
Gibbs LM, Addington-Hall J, Gibbs JS: Dying from heart failure: Lessons from palliative care. BMJ. 1998; 317(7164): 961-962.
71.
Gibbs JS, McCoy AS, Gibbs LM, et al.: Living with and dying from heart failure: The role of palliative care. Heart. 2002; 88(Suppl 2): ii36-ii39.
72.
Murray SA, Boyd K, Kendall M, et al.: Dying of lung cancer or cardiac failure: Prospective qualitative interview study of patients and their carers in the community. BMJ. 2002; 325(7370): 929.
73.
McCarthy M, Hall JA, Ley M: Communication and choice in dying from heart disease. J R Soc Med. 1997; 90(3): 128-131.
74.
McCarthy EP, Phillips RS, Zhong Z, et al.: Dying with cancer: Patients’ function, symptoms, and care preferences as death approaches. J Am Geriatr Soc. 2000; 48(5 Suppl): S110-S121.
75.
Gannon C: Palliative care in terminal cardiac failure: Hospices cannot fulfill such a vast and diverse role. BMJ. 1995; 310(6991): 1410-1411.
76.
Jones S: Palliative care in terminal cardiac failure. BMJ. 1995; 310(6982): 805.
77.
Thorns AR, Gibbs LM, Gibbs JS: Management of severe heart failure by specialist palliative care. Heart. 2001; 85(1): 93.
78.
Beattie JM, Murray RG, Brittle J, et al.: Letter: Palliative care in terminal cardiac failure. BMJ (Clin Res Ed). 1995; 310 (6991): 1411.
